Hi, I'm AJOVY® Bot.

Click here to ask questions about AJOVY®

This site uses cookies to give you a better browsing experience.

You can find out more about the cookies we use here.

X Close

Are you a healthcare professional?

To access this section of the AJOVY® website you need to be a member of the healthcare profession because the materials included in this area of our website are specifically prepared for that audience only.

Please click on the appropriate button below to confirm that you are a healthcare professional.

I AM A HEALTHCARE PROFESSIONAL I AM NOT A HEALTHCARE PROFESSIONAL
  • Prescribing Information
  • AE Reporting
  • Important Safety Information
  • Continue to tevapharm.com
Menu

AJOVY® is indicated for prophylaxis of migraine in adults who have at least four migraine days per month1

Menu
  • Moa /**/ /**/ /**/ /**/ /**/ /**/ /**/
  • Trials /**/ /**/ /**/ /**/ /**/ /**/ /**/
  • Efficacy /**/ /**/ /**/ /**/ /**/ /**/ /**/
  • Safety profile /**/ /**/ /**/ /**/ /**/ /**/ /**/
  • Flexibility /**/ /**/ /**/ /**/ /**/ /**/ /**/
  • Administration /**/ /**/ /**/ /**/ /**/ /**/ /**/
  • Resources /**/ /**/ /**/ /**/ /**/ /**/ /**/

YOU ARE NOW LEAVING THIS WEB SITE

This Web site may contain links or references to other Web sites maintained by third parties over whom Teva, Inc. ("Teva") has no control. Links are provided as a convenient resource to our visitors. We carefully choose Web sites which we believe are useful based on our high standards. However, Web sites can change. Teva cannot guarantee the standards of every Web site link or be responsible for the content of non-Teva Web sites. Inclusion of any third-party link does not imply an endorsement or recommendation by Teva.

Similarly, this Web site may be accessed from third-party links over which Teva has no control. Teva makes no warranties or representations of any kind as to the accuracy, currency, or completeness of any information contained in such Web sites and shall have no liability for any damages or injuries of any kind arising from such content or information.

Continue Stay Here

Privacy and Cookie Notice

This website ("the Site") is operated by Teva Pharmaceutical Industries Ltd. ("Teva") and its affiliates. You can view a list of all the Teva affiliates at the following website: http://www.tevapharm.com. Teva is referred to in this privacy notice as “we”, “us” and “our.”

 

Scope of this Privacy Notice

This Privacy Notice applies to personal data we collect through the Site. It describes how we use your data and your data protection rights, including a right to object to some of the processing which we carry out. More information about your rights, and how to exercise them, is set out in the “How we store your information and your rights” section.

 

Our Site may include links to other websites over which we have no control. Teva is not responsible for the privacy policies or practices of other websites. We may also link to other websites operated by Teva or Teva’s affiliated companies which operate under separate privacy policies. If you access these websites via our Site, you should review the privacy policies of those sites so you can understand how they collect, use and share your information.

 

How we use your information

We process the personal data we collect for the following purposes:

  • with your consent to:
    • provide you with information on Teva’s business activities, products or services
    • respond to your queries or other correspondence you have submitted through the Site
    • place cookies and similar technologies, as described below
  • to allow us to pursue our legitimate business interests, in particular to:
    • analyse the use of our Site in order to continuously improve content and measure performance
    • optimize and tailor the use of our Site and our communication to you
  • to meet legal, regulatory, pharmacovigilance and compliance requirements, in particular to respond to requests for information from government authorities.

 

Sharing your personal data

Teva may disclose your personal data to the following categories of recipients (in all cases, only when necessary to fulfil their functions):

  • our staff (including employees and external consultants), professional advisors and agents;
  • other functions and companies in the Teva group of companies worldwide;
  • third party service providers which process your personal data on behalf of Teva and who are bound by contractual obligations to keep your personal data confidential and appropriately secure;
  • purchasers, or potential purchasers, of all or part of Teva's business (and their professional advisors); and
  • government authorities, regulatory agencies and law enforcement officials, if required for the purposes specified above, if mandated by law, or if required for the legal protection of our legitimate interests in compliance with applicable laws.

 

Cookies and related tracking technologies

 

Use of Cookies on the Site

Teva uses cookies to collect information about you and store your online preferences. Cookies are text files containing small amounts of information which are downloaded to your device when you visit a website. Cookies are then sent back to the website when you return to it: this is useful because it allows the website to recognise your device. To find out more about cookies please visit www.allaboutcookies.org Teva uses the following categories of cookies on the Site:

Category 1: Strictly Necessary Cookies

These cookies are essential in order to enable you to move around the Site and use its features. Without these cookies, services you have asked for (such as remembering your login details) cannot be provided.

Category 2: Performance Cookies

These cookies collect information on how people use the Site. For example, Teva uses these cookies to help us understand how customers arrive at the Site, browse or use the Site and highlight areas where we can improve areas such as navigation, user experience and marketing campaigns. All information these cookies collect is aggregated and therefore anonymous. It is only used to improve how the Site works.

Category 3: Functionality Cookies

These cookies remember choices you make (such as language choices). These can then be used to provide you with an experience more appropriate to your selections and to make your visits to the Site more tailored. The information these cookies collect may be anonymised and they cannot track your browsing activity on other websites.

If you want to delete any cookies that are already on your computer, please refer to the help and support area on your internet browser for instructions on how to locate the file or directory that stores cookies. Information on deleting or controlling cookies is also available at www.allaboutcookies.org. Please note that by deleting our cookies (or disabling future cookies) you may not be able to access certain areas or features of the Site.

 

Use of Web Beacons

Some pages of our Site and e-mails we may send may contain electronic images known as web beacons (sometimes known as clear gifs) that allow us to count users who have visited these pages or read our e-mails. Web beacons collect only limited information which include a cookie number, time and date of a page view, and a description of the page on which the web beacon resides. These beacons do not carry any personal data and are only used to track the effectiveness of a particular campaign.

 

How we store your information and your rights

We retain all the information we gather about your interactions with Teva. Your information will be retained for two years, or as reasonably necessary for the purposes set out above, in accordance with applicable laws.

You may be entitled under applicable law to ask Teva for a copy of your information, to correct it, erase or restrict its processing, or to ask us to transfer some of this information to other organisations. You may also have rights to object to some processing. These rights may be limited in some situations – for example, where we can demonstrate we have a legal requirement to process your personal data.

Where you have consented to the processing of your data, you may withdraw such consent at any time.

To exercise any of your rights in relation to your personal data, please contact us. If you live in Europe, please contact us at EUPrivacy@tevaeu.com. For all other regions, please contact us at IL_Privacy.Tevail@teva.co.il.

We hope that we can satisfy any queries you may have about the way in which we process your personal data. If you have any concerns about how we process your personal data, you can get in touch with Teva’s Data Protection Office by contacting us. If you live in Europe, you can contact us at EUPrivacy@tevaeu.com. However, if you have unresolved concerns you also have the right to complain to the data protection authority in the location in which you live, work or believe a data protection breach has occurred.

 

International transfers

Teva operates internationally and will transfer your information to countries outside your own country and outside the European Economic Area, including to Israel and the United States. When transferring your information to Israel, Teva relies on the European Commission’s adequacy decision with respect to the transfer of data from the European Union to Israel; when transferring to the US, Teva uses Teva Pharmaceutical USA Ltd.’s Privacy Shield certification; when transferring to other countries outside the EEA, Teva generally relies on EU Commission approved standard contractual clauses. Information on the relevant mechanism can be provided upon request to EUprivacy@tevaEU.com.

 

Changes to this Privacy Notice

If our privacy policy changes in any way, Teva will place an updated version of the policy on this page. Regularly reviewing this page ensures that you are always aware of what information we collect, how Teva uses it and under what circumstances, if any, we will share it with other parties.

Effective: March 2018

Significantly more migraine-free days vs placebo1-5

Efficacy of ajovy®
Continue to Dosing flexibility page of AJOVY

Flexibility to help you meet your patients' needs1,5

Flexibility of ajovy®
Continue to Safety page of AJOVY

A generally well-tolerated treatment choice1-5

safety profile of ajovy®

Important Safety Information

Contraindications: AJOVY® is contraindicated in patients with hypersensitivity to fremanezumab or to any of the excipients1

Hypersensitivity Reactions: Hypersensitivity reactions were reported with fremanezumab in less than 1% of patients in clinical trials. If a hypersensitivity reaction occurs, discontinuation of fremanezumab administration should be considered and appropariate therapy should be initiated1

Adverse Events: The most common adverse reactions were injection site reactions1

Indication

AJOVY® is indicated for prophylaxis of migraine in adults who have at least four migraine days per month1

Please see the Full Prescribing Information for AJOVY®

Adverse events should be reported. Reporting forms and information can be found at www.gov.uk/yellowcard.
     Adverse events should also be reported to Teva UK Limited on 0207 540 7117 or medinfo@tevauk.com

References: 1. AJOVY® SmPC. Teva UK. Limited. 2. Dodick DW et al. JAMA. 2018; 319(19): 1999−2008. 3. Silberstein SD et al. N Engl J Med. 2017; 377(22): 2113−2122. 4. Newman LC et al. Long-term impact of fremanezumab on response rates: Results of a 1-year study. Poster presented at: The 13th European Headache Federation (EHF) Congress; May 30–June 1, 2019; Athens, Greece. 5. Ferrari MD et al. Lancet 2019; doi: 10.1016/S0140-6736(19)31946-4. 

Back to top
Legal Notice
Privacy Notice
Prescribing Information
Site Map
PAAB Logo

UK/FREM/19/0022(1) | Date of Preparation: August 2020 | Teva UK Limited, Ridings Point, Whistler Drive, Castleford, WF10 5HX